title: [Hematology 2009].
authors.affiliation: Medizinische Klinik III der Universität München - Grosshadern, München. martin.dreyling@med.uni-muenchen.de
authors.forename: M
authors.initials: M
authors.lastname: Dreyling
authors.forename: K
authors.initials: K
authors.lastname: Spiekermann
authors.forename: W
authors.initials: W
authors.lastname: Hiddemann
mesh_terms: D019337:Hematologic Neoplasms / Q000145:classification / Q000175:diagnosis* / Q000628:therapy; D006405:Hematology / Q000639:trends*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000628:therapy; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis; D008224:Lymphoma, Follicular / Q000628:therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy; D009101:Multiple Myeloma / Q000628:therapy; D011379:Prognosis; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000175:diagnosis / Q000628:therapy; D054556:Venous Thromboembolism / Q000517:prevention & control
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors